Login
$ANIP
$70.84 -$0.60 (0.84%) Live

Company Executives

Officer Age In this role 2025 pay Source
Nikhil Lalwani Also a director
President and Chief Executive Officer
48 Not stated $10,278,620
Stephen P. Carey
Senior Vice President, Finance and Chief Financial Officer
55 Since 2020
6 years
$3,251,862
Krista Davis
Senior Vice President and Chief Human Resources Officer
53 Since 2022
4 years
Not reported
Meredith W. Cook
SR. VP, GENERAL COUNSEL & SEC.
Title from the Form 4 dated Nov 13, 2026
52 Not stated $2,318,421
Muthusamy Shanmugam
Head of Research & Development and Chief Operating Officer of New Jersey Operations
58 Not stated Not reported
Chad Gassert
Senior Vice President, Corporate Development & Strategy
50 Since 2021
5 years
Not reported
Ori Gutwerg
Senior Vice President, Generics
52 Since 2021
5 years
$2,309,559
Christopher K. Mutz
Senior Vice President, Head of Rare Disease
55 Since 2021
5 years
$3,396,694
Thomas Rowland
Senior Vice President, Head of Established Brands
60 Since 2021
5 years
Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Apr 9, 2026 · updated by the 8-K of Aug 24, 2026

Directors
8
serving now
Independent
6 of 6
stated in the proxy; 2 not stated
Average tenure
5.5 years
from year joined
CEO also chairs the board
No
Thomas J. Haughey
Director Age On board Independent Committees Other public boards 2025 pay Source
Thomas J. Haughey
62 2018
8 years
Independent
Audit and Finance
None stated $343,089
Nikhil Lalwani
48 2020
6 years
Not stated None stated None stated Paid as CEO
Matthew J. Leonard
60 2023
3 years
Independent
Audit and Finance
None stated $327,573
Antonio R. Pera
68 2020
6 years
Independent
Compensation · Chair
None stated $327,573
Renee P. Tannenbaum
74 2022
4 years
Independent
Compensation Nominating and Corporate Governance · Chair
Cardiff Oncology, Inc. $332,573
Jeanne A. Thoma
66 2020
6 years
Independent
Audit and Finance · Chair Compensation
Nanoform Finland Oyj $331,330
Henry Gosebruch Joined Aug 19, 2026
- - - - - -
Patrick D. Walsh Leaving at the meeting
Not stated Not stated Independent None stated None stated $345,800

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.

No related-party transactions disclosed

The proxy filed Apr 9, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support